Detail Information of Xenobiotics-driven Alterations in 3D Complexes
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0418 Transporter Info | ||||
| Gene Name | SLC5A1 | ||||
| Transporter Name | Sodium/glucose cotransporter 1 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Xenobiotics-driven Alterations in 3D Complexes (XSV) of This DT | |||||
| Xenobiotic Name | Phlorizin Drug Info | ||||
| Xenobiotic Type | Investigative Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 6072 | ||||
| Docking Score | -10.331 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C21H24O10 | ||||
| Molecular Weight | 436.4 | ||||
| Canonical SMILES |
C1=CC(=CC=C1CCC(=O)C2=C(C=C(C=C2O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)O)O
|
||||
| InChI |
InChI=1S/C21H24O10/c22-9-16-18(27)19(28)20(29)21(31-16)30-15-8-12(24)7-14(26)17(15)13(25)6-3-10-1-4-11(23)5-2-10/h1-2,4-5,7-8,16,18-24,26-29H,3,6,9H2/t16-,18-,19+,20-,21-/m1/s1
|
||||
| InChIKey | IOUVKUPGCMBWBT-QNDFHXLGSA-N | ||||
| Pharmaceutical Properties | Xlogp | 1.2 | Rotatable Bond Count | 7 | |
| Hydrogen Bond Donor Count | 7 | Hydrogen Bond Acceptor Count | 10 | ||
| Xenobiotic Name | Alstiphyllanine E Drug Info | ||||
| Xenobiotic Type | Investigative Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 46229071 | ||||
| Docking Score | -10.27 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C30H32N2O7 | ||||
| Molecular Weight | 532.6 | ||||
| Canonical SMILES |
C/C=C\\1/CN2[C@H]3C[C@@H]1[C@@]([C@@]45[C@@]3(NC6=CC=CC=C64)O[C@H]2C5)(COC(=O)C7=CC(=C(C=C7)OC)OC)C(=O)OC
|
||||
| InChI |
InChI=1S/C30H32N2O7/c1-5-17-15-32-24-13-20(17)28(27(34)37-4,16-38-26(33)18-10-11-22(35-2)23(12-18)36-3)29-14-25(32)39-30(24,29)31-21-9-7-6-8-19(21)29/h5-12,20,24-25,31H,13-16H2,1-4H3/b17-5-/t20-,24-,25-,28-,29-,30-/m0/s1
|
||||
| InChIKey | NPAPHJSGCRCHBM-UMLFCLJTSA-N | ||||
| Pharmaceutical Properties | Xlogp | 3.4 | Rotatable Bond Count | 8 | |
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 9 | ||
| Xenobiotic Name | LIK-066 Drug Info | ||||
| Xenobiotic Type | Drug in Phase 2 Trial | ||||
| MOA | Inhibition | ||||
| PubChem CID | 52913524 | ||||
| Docking Score | -10.125 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C23H28O7 | ||||
| Molecular Weight | 416.5 | ||||
| Canonical SMILES |
CCC1=C(C=C(C=C1)[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)CC3=CC4=C(C=C3)OCCO4
|
||||
| InChI |
InChI=1S/C23H28O7/c1-2-14-4-5-15(23-22(27)21(26)20(25)19(12-24)30-23)11-16(14)9-13-3-6-17-18(10-13)29-8-7-28-17/h3-6,10-11,19-27H,2,7-9,12H2,1H3/t19-,20-,21+,22-,23+/m1/s1
|
||||
| InChIKey | XFJAMQQAAMJFGB-ZQGJOIPISA-N | ||||
| Pharmaceutical Properties | Xlogp | 1.9 | Rotatable Bond Count | 5 | |
| Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 7 | ||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.